With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Reciprocal interactions between tumor killer dendritic cells and tumor-induced regulatory T lymphocytes||University of Arizona / Nicolas Larmonier, PhD||Young Investigator Grants||2008||Arizona|
|MDM2 as an Effector of Hedgehog Signaling in Brain Development and Medulloblastoma||Purdue University / Susan Mendrysa, PhD||Young Investigator Grants||2008||Indiana|
|A mouse model of Wilms' Tumor||Massachusetts General Hospital / Nabeel Bardeesy, PhD||Young Investigator Grants||2008||Massachusetts|
|Genomic Alterations in Medulloblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Young Investigator Grants||2008||California|
|The TC3 Line, a Zebrafish Model of T-Cell Malignancy||Huntsman Cancer Institute / Nathan Meeker, MD||Young Investigator Grants||2008||Utah|
|Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.||Baylor College of Medicine / Eveline Barbieri, MD, PhD||Young Investigator Grants||2008||Texas|
|Untangling the Matrix in Medulloblastoma||St. Christopher's Hospital for Children / Duncan Stearns, MD||Young Investigator Grants||2008||Ohio|
|Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors||Harbor - UCLA Medical Center / Joseph Lasky||Young Investigator Grants||2008||California|
|Identification and Validation of Differentiation Therapy for Osteosarcoma||Dana-Farber Cancer Institute / Katherine Janeway, MD||Young Investigator Grants||2008||Massachusetts|
|Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide||University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD||Young Investigator Grants||2008||Texas|